NCT03418038 2026-04-16Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic LeukemiaMayo ClinicPhase 2 Recruiting80 enrolled
NCT04442022 2025-10-03A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell LymphomaKaryopharm Therapeutics IncPhase 2/3 Recruiting501 enrolled